Uganda extends lockdowns as Ebola spreads
Uganda on Saturday extended a three-week lockdown on two districts at the center of an Ebola outbreak which has claimed over 50 lives, curbing travel and closing public places.
Nov 6, 2022
0
51
Uganda on Saturday extended a three-week lockdown on two districts at the center of an Ebola outbreak which has claimed over 50 lives, curbing travel and closing public places.
Nov 6, 2022
0
51
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
Nov 3, 2022
0
23
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute (DHVI) has demonstrated wide protection against SARS-CoV-2 viruses and variants, including omicron BA.5.
Oct 28, 2022
0
128
A vaccine candidate called R21 has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.
Sep 15, 2022
0
6
A new universal flu vaccine protects against diverse variants of both influenza A and B viruses in mice, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
Aug 25, 2022
1
141
World-first immunizations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades.
Aug 23, 2022
0
173
A vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) was found to be safe, well-tolerated and induced a neutralizing antibody response ...
May 12, 2022
0
7
Coronavirus-like particles (CoVLP), which are produced in plants, combined with an adjuvant (Adjuvant System 03 [AS03]) forms a candidate vaccine that is effective for preventing COVID-19, according to a study published online ...
May 5, 2022
0
63
Griffith University researchers have developed a potential vaccine for a pathogen that causes severe infection in immunocompromised people and is particularly prevalent in hospitals.
Apr 13, 2022
0
8
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR ...
Apr 12, 2022
0
6